More niche examples can also be found, such as microarrays and specialist medical
diagnostics devices such as the Triage® cardiac panel (BiositeInc, USA) [5] and the i-Stat (Abbott Laboratories,
USA). It is somewhat unclear why these devices have been more successful than their more modern and more
integrated functionality modern counterparts, but it is believed we are converging closer to the answers. With respect
to devices such as the Triage® cardiac panel and i-Stat, despite their well-developed technology, proven functionality
and aesthetically pleasing designs, their uptake as the benchmark device/technique of preference in their intended
utility within a clinical capacity, has been limited. The reason for this are multi-fold, but primarily are attributed to
cost constraints for a given hospital/clinic and issues relating to user training/clear route for information relay, which
ultimately don’t provide clinicians an added value which far exceeds current practices.